Recent Research Analysts’ Ratings Changes for Celestica (CLS)

Celestica (NYSE: CLS) recently received a number of ratings updates from brokerages and research firms:

• 8/7/2026 – Celestica had its price target lowered by Barclays PLC from $430.00 to $406.00. They now have an “overweight” rating on the stock.
• 7/30/2026 – Celestica was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
• 7/29/2026 – Celestica had its price target raised by Canadian Imperial Bank of Commerce from $480.00 to $500.00. They now have an “outperform” rating on the stock.
• 7/29/2026 – Celestica had its “buy” rating reaffirmed by Bank of America Corporation.
• 7/29/2026 – Celestica had its “neutral” rating reaffirmed by UBS Group AG. They now have a $410.00 price target on the stock.
• 7/29/2026 – Celestica had its price target lowered by Barclays PLC from $441.00 to $430.00. They now have an “overweight” rating on the stock.
• 7/29/2026 – Celestica had its price target raised by Wolfe Research from $425.00 to $475.00. They now have an “outperform” rating on the stock.
• 7/29/2026 – Celestica had its price target raised by Royal Bank Of Canada from $440.00 to $450.00. They now have an “outperform” rating on the stock.
• 7/29/2026 – Celestica had its price target raised by JPMorgan Chase & Co. from $445.00 to $485.00. They now have an “overweight” rating on the stock.
• 7/28/2026 – Celestica was given a new $500.00 price target by Stifel Nicolaus.
• 7/28/2026 – Celestica had its “buy” rating reaffirmed by BWS Financial.
• 7/16/2026 – Celestica was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 6/26/2026 – Celestica was upgraded by Zacks Research from “hold” to “strong-buy”.

Insider Activity

In other news, Director Michael Max Wilson sold 4,168 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the transaction, the director owned 24,718 shares in the company, valued at approximately $8,238,756.58. This trade represents a 14.43% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Mandeep Chawla sold 17,000 shares of Celestica stock in a transaction on Monday, June 15th. The shares were sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the completion of the sale, the chief financial officer directly owned 82,444 shares of the company’s stock, valued at approximately $32,948,744.60. The trade was a 17.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 337,225 shares of company stock worth $128,112,965. 1.10% of the stock is owned by corporate insiders.

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.